Uravan Announces the Purchase of Uranium Claims in Lisbon Valley

CALGARY, AB, Aug. 15, 2022 /CNW/ – Uravan Minerals Inc. (TSXV: UVN) (" Uravan ") and Prime Fuels Corp (" Prime ") announce they have entered into a Share Purchase Agreement effectively dated August 9, 2022 (the " Transaction" ) which sets forth the terms and conditions upon which Uravan will acquire Prime and its 100% owned mining projects located in Lisbon Valley Mining District (the "Lisbon Valley District" ) Utah, USA.

Prime is a private company incorporated under the laws of the State of Colorado and is the recorded and beneficial owner of a 100% interest in certain unpatented lode mining claims (the " Claims ") situated in the State of Utah, USA. The Claims consist of two groups, the LS and JB mining claims, totalling 107 claims covering approximately 2,211 acres (895 ha) in the Lisbon Valley District, south-eastern Utah.

The Lisbon Valley District is in the Colorado Plateau […]

About the author: StockMan
Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.
Posting Guidelines
Do
  • Do contribute something to the discussion
  • Do post factual information, analysis and your view on company valuations
  • Do disclose if you have an interest in a security
  • Do take our Terms of Use seriously
Do Not
  • Do not make low-content posts, unsubstantiated ramps or untruthful/misleading statements
  • Do not complain about a post unless you have reported it first, and not on the forum.
  • Do not post financial advice
  • Do not advertise or post sponsored content

Get involved!

Get Connected!

Come and join our community. Expand your network and get to know new people!

Comments

No comments yet